Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia

Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia

Background: Ceftazidime-avibactam (CZA) is the preferred treatment for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). This study aimed to investigate the prognostic factors of 28-day mortality and 14-day clinical failure in patients treated with CZA for CZA-susceptible CRKP...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi-Tsung Lin, Shih-Neng Lin, Chien Chuang, Szu-Yu Liu, Yu-Chien Ho, Chih-Han Juan, Hsiang-Ling Ho, Sheng-Hua Chou
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Journal of Infection and Public Health
Subjects:
Ceftazidime-avibactam
Bacteremia
Mortality
Risk factors
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034125001856
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items